Every part of Calophyllum inophyllum L. has been used in various traditional remedies, especially the oil from its nut was mostly used to treat skin diseases. This study aimed to investigate the composition and antioxidant activity of C. inophyllum nut oil and formulate the oil as a cosmeceutical product. The chemical composition and the amount of total phenolic compounds (TPC) were demonstrated by Gas Chromatograph-Mass Spectrometer (GC-MS) and Folin–Ciocalteu method, respectively. Additionally, the antioxidant activity was tested using the DPPH method. Calophyllolide (4.35%) was a major component. Additional components were calanolide A, inophyllum D, and inophyllum B. We found that the TPC contained 25.9 ± 1.2 mg GE/g oil and a free radical scavenging activity approximate to that of the synthetic Trolox. Emulgel formulation consisted of tween 80, span 80, and isopropyl alcohol as a surfactant, and carbopol 940 as a gelling agent. The microemulsion was formulated using distilled water, oil, tween 80 with span 80, as a surfactant, and isopropyl alcohol as a cosurfactant. The mean droplet size for optimized microemulsion formulations was 34.37 ± 1.06 nm. Furthermore, the results of thermodynamic stability tests (freeze-thaw cycle) and long-term stability tests indicated that emulsions and microemulsions remained stable. In conclusion, this nut oil could potentially be used as a cosmeceutical product, and the obtained emulgels and microemulsions exhibited good characteristics in terms of being a potential agent for skin antioxidant.
Context: First-line therapy using artemisinin-based combination therapy (ACT) and chloroquine in cases of malaria infection has developed resistance worldwide. Aims: To synthesize functionalized dibenzylideneacetones that are similar to curcumin and to perform the in silico evaluations on Plasmodium falciparum enoyl acyl carrier protein reductase (PfENR) and through human dihydrofolate reductase (hDHFR) as targets for antimalarial agents. Methods: The functionalized dibenzylideneacetones were synthesized through a reaction of acetone with benzaldehydes in a base or acid catalyst. The resulting solids were purified by recrystallization to conduct UV/Vis, FTIR, and NMR tests. The confirmed products underwent an in silico molecular docking test on PfENR (PDB ID: 1NHG) and hDHFR (PDB ID: 1MVT). The products were obtained in good yields. Results: The confirmed products underwent in silico molecular docking test on PfENR (PDB ID: 1NHG) and hDHFR (PDB ID: 1MVT). The products were obtained with good yields. Based on in silico results, the dibenzylideneacetone was predicted to have a strong potential to inhibit the growth of malaria parasites through inhibit malaria growth through the PfENR pathway more than through the hDHFR pathway because its moldock score was lower than its native ligand. Conclusions: This study showed a promising pathway to obtain antimalarial agents for further application in the medical and pharmaceutical industries.
J. Pharm. Pharmacogn. Res., vol. 11, no. 6, pp. 1123-1136, Nov-Dec 2023. DOI: https://doi.org/10.56499/jppres23.1718_11.6.1123 Original Article QSAR study of benzylidene hydrazine benzamides derivatives with in vitro anticancer activity against human lung cancer cell line A459 [Estudio QSAR de derivados de benzilideno hidrazina benzamidas con actividad anticancerígena in vitro frente a la línea celular de cáncer de QSAR study of benzylidene hydrazine benzamides derivatives with in vitro anticancer activity against human lung cancer cell line A459
MicroRNAs (miRNAs), derived from extracellular vesicles (EVs) are circulating intercellular communicators which influence pathogenesis and could be used as potential diagnostic markers. In this study, plasma-derived EVs from Plasmodium knowlesi-infected patients (n = 13) and healthy individuals (n = 10) were isolated using size exclusion chromatography and ultracentrifugation. The presence of EVs was confirmed by transmission electron microscopy and Western immunoblotting, and quantified by nanoparticle tracking analysis. The EVs isolated from patients exhibited a larger size, accompanied by an elevated concentration of EVs. The relative expression levels of 8 human miRNAs were quantified using reverse transcriptase quantitative polymerase chain reaction. Compared to uninfected groups, hsa-miR-223-5p (P-value = 0.0002) and hsa-miR-486-5p (P-value = 0.025) were upregulated in P. knowlesi-infected patients. Bioinformatic analysis revealed that these miRNAs are predicted to target both human host and parasite genes, and they were found to be enriched in various malaria-related pathways. The areas under the receiver operating characteristic curve of hsa-miR-223-5p and hsa-miR-486-5p were 0.9154 and 0.8231, respectively, suggesting the potential of EV-miRNAs as diagnostic markers. Results revealed that EV-miRNAs may play a significant role in the progression of P. knowlesi infection. Further investigations should explore their potential impact on gene expression regulation as diagnostic biomarkers or targets for therapeutic interventions.